Results 231 to 240 of about 49,600 (309)
Schwann cell deletion of <i>Tumor Susceptibility Gene 101</i> ( <i>Tsg101</i> ) in mice results in severe peripheral neuropathy. [PDF]
Silvius D+5 more
europepmc +1 more source
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes
ABSTRACT Background and Aims Charcot–Marie–Tooth disease (CMT) is a rare hereditary neuropathy that affects peripheral nerves in the upper and lower limbs. To distinguish between the different forms of the disease, electrophysiological criteria are essential.
Endrit Shumeri+10 more
wiley +1 more source
Roles for PMP22 in Schwann cell cholesterol homeostasis in health and disease. [PDF]
Stefanski KM, Wilkinson MC, Sanders CR.
europepmc +1 more source
Cell death in the Schwann cell lineage and its regulation by neuregulin.
Daniel E. Syroid+7 more
openalex +1 more source
ABSTRACT Background and Aims Mitochondrial trifunctional protein deficiency (MTPD) is an inherited disorder of fatty acid β‐oxidation caused by mutations in HADHA or HADHB genes. It typically presents with cardiomyopathy or hepatic failure in early childhood; however, it may rarely present in adulthood with the neuromyopathic form.
Farkhanda Qaiser+6 more
wiley +1 more source
iPSC-based merlin-deficient Schwann cell-like spheroids as an <i>in vitro</i> system for studying <i>NF2</i> pathogenesis. [PDF]
Catasús N+14 more
europepmc +1 more source
ABSTRACT Objective This study aimed to investigate the potential role of cesium chloride (CsCl), ivabradine (IVA), and isoproterenol (ISO) on the sensory transmission of bladder afferents to graded urinary bladder distension (UBD). We specifically selected these drugs to target the hyperpolarization‐activated cyclic nucleotide‐gated (HCN) cation ...
Eric Woon+5 more
wiley +1 more source
Pancreatic cancer extracellular vesicles stimulate Schwann cell activation and perineural invasion in vitro via IL-8/CCL2. [PDF]
Gregory E+4 more
europepmc +1 more source
Neuroimmune pathophysiology of long COVID
Although COVID‐19 was originally considered a respiratory illness, it is now well established that SARS‐CoV‐2 infection can have far‐reaching impacts on the nervous system. Neurological symptoms such as chemosensory dysfunction are frequently observed during acute infection and approximately 10% of COVID‐19 cases will go on to develop new or persistent
Janna K. Moen+2 more
wiley +1 more source